A bill to encourage domestic advanced manufacturing of critical drugs and devices in order to address economic, health, and security concerns, combat shortages of critical drugs and devices, and promote increased domestic diversification of, and independence from foreign reliance on, pharmaceutical and medical device supply chains.
About This Bill
Committee
Latest Action · May 20, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.